Benefits and Harms of Omalizumab Treatment in Adolescent and Adult Patients With Chronic Idiopathic (Spontaneous) Urticaria: A Meta-analysis of "Real-world" Evidence

Treatment response to omalizumab in patients with refractory chronic spontaneous urticaria

Int J Dermatol.

Syrigos N, Grapsa D, Zande M, Tziotou M, Syrigou E

doi: 10.1111/ijd.13935.

Rheumatoid Arthritis

Glucocorticoid-trials in rheumatoid arthritis mostly study representative real-world patients: A systematic review and meta-analysis

Semin Arthritis Rheum.

Palmowski A, Nielsen SM, Buttgereit T, Palmowski Y, Boers M, Christensen R, Buttgereit F

doi: 10.1016/j.semarthrit.2020.02.016.

Atopic Dermatitis

Real-world evidence of dupilumab efficacy and risk of adverse events: a systematic review and meta-analysis

J Am Acad Dermatol.

Halling AS, Loft ND, Silverberg JI, Guttman-Yassky E, Thyssen JP

doi: 10.1016/j.jaad.2020.08.051.

Psoriasis

Persistence of apremilast in moderate-to-severe psoriasis. A real-world analysis of 14,147 apremilast- and methotrexate-naive patients in the French national health insurance database

Br J Dermatol.

Sbidian E, Billionnet C, Weill A, Maura G, Mezzarobba M

doi: 10.1111/bjd.18047.

Atopic Dermatitis

Prevalence of type 2 inflammatory diseases in pediatric patients with atopic dermatitis: real-world evidence

J Am Acad Dermatol

Paller AS, Mina-Osorio P, Vekeman F, Boklage S, Mallya UG, Ganguli S, Kaur M, Robitaille MN, Siegfried EC

doi: 10.1016/j.jaad.2021.10.038

Further Publications Dermatology

Comparison of Two-Year Treatment Adherence, Persistence, Discontinuation, Re-initiation, and Switching Between Psoriasis Patients Treated with Ixekizumab or Secukinumab in Real-World Settings

J Am Acad Dermatol

Blauvelt A, Shi N, Somani N, Burge R, Zhu B, Ridenour TL, Lew CR, Zimmerman NM, Atiya B, Murage MJ

doi: 10.1016/j.jaad.2021.06.878

Juvenile Idiopathic Arthritis

Real-World Effectiveness of Common Treatment Strategies for Juvenile Idiopathic Arthritis: Results from a Canadian Cohort

Arthritis Care Res (Hoboken).

Chhabra A, Oen K, Huber AM, Shiff NJ, Boire G, Benseler SM, Berard RA, Scuccimarri R, Feldman BM, Lim LSH, Barsalou J, Bruns A, Cabral DA, Chédeville G, Ellsworth J, Houghton K, Lang B, Morishita K, Rumsey DG, Rosenberg AM, Tse SM, Duffy KW, Duffy CM, Guzman J, ReACCh-Out Investigators

doi: 10.1002/acr.23922.

Melanoma and Skin CancerPsoriasis

Systematic review of the real-world evidence of adalimumab safety in psoriasis registries

J Eur Acad Dermatol Venereol.

Strober B, Crowley J, Langley RG, Gordon K, Menter A, Leonardi C, Arikan D, Valdecantos WC

doi: 10.1111/jdv.15203.

Acne

Real-world effectiveness of adalimumab in patients with moderate to severe hidradenitis suppurativa: The 1-year SOLACE study

J Eur Acad Dermatol Venereol

Gulliver W, Alavi A, Wiseman MC, Gooderham MJ, Rao J, Alam MS, Papp KA, Desjardins O, Jean C

doi: 10.1111/jdv.17598

Related content